Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority…

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 66 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 492 followers.

[schizo] Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with… https://t.co/9280pUiGod

Reply Repost Favourite

Significant reduction in caregiver burden with LAIs. Carers burden in Asia very high @DovePress https://t.co/GMm5FVDRbP https://t.co/spd9Y4aEfV

Reply Repost Favourite

Great new article on PP3M efficacy in Asian patients with schizophrenia @DovePress https://t.co/GMm5FVDRbP https://t.co/GLqUmJ2Z0O

Reply Repost Favourite

Efficacy and safety of paliperidone palmitate three-month @DovePress https://t.co/GMm5FVDRbP

Reply Repost Favourite